Targanta Therapeutics' IPO

Targanta Therapeutics raised a round of funding on October 10, 2007. Investors include Public.

Targanta Therapeutics, Inc. (NASDAQ:TARG) is a biotechnology company developing and commercializing antibacterial drugs to treat serious infections in the hospital setting. Targanta's lead drug candid…

Articles about Targanta Therapeutics' IPO: